Remove Leads Remove Pharma Remove Transportation
article thumbnail

The impact of climate change on the pharma supply chain

Pharmaceutical Technology

And delays in the supply chain, even for short periods of time can potentially affect the efficacy of medicines, lead to longer-term supply bottlenecks, and ultimately prevent people from getting access to the critical medicines they need. Consumers are taking notice of these metrics, and there is demand for action from pharma.

Pharma 142
article thumbnail

Leading retail pharmacies in pharma

Pharmaceutical Technology

Increasing diagnosis of chronic diseases is expected to lead to fast growth in retail pharmacies. Integrating AI into the operations of retail pharmacies helps in improving the decision-making process, order fulfilment, demand forecasting, and monitoring of the transportation and storage environment.

Retail 45
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Roche deepens ties with Jnana with a second licensing deal

pharmaphorum

Swiss pharma group Roche has doubled down on a partnership with Jnana Therapeutics, paying $50 million upfront to tap into the Boston-based biotech drug discovery platform for a wide-ranging push across cancer, immune-mediated, and neurological diseases.

article thumbnail

Leading pharmaceutical wholesalers

Pharmaceutical Technology

Pharmaceutical Technology has listed some of the leading wholesalers of pharmaceutical products based on its intel, insights, and decades of experience in the sector. The post Leading pharmaceutical wholesalers appeared first on Pharmaceutical Technology. Discover the top pharmaceutical wholesalers. GDP and GMP advisory.

Leads 52
article thumbnail

Ipsen concludes purchase of Albireo Pharma

Pharmaceutical Technology

French biopharmaceutical firm Ipsen has concluded the purchase of US-based Albireo Pharma , expanding its rare disease portfolio. Albireo’s pipeline includes its lead asset, Bylvay (odevixibat), a potent, once-a-day, oral, non-systemic, ileal bile acid transport inhibitor (IBATi).

article thumbnail

How one pharma “family business” places patients first

pharmaphorum

When people think about pharma, they often think about “big” pharma: large, faceless corporations. Every pharma company developing treatments for new diseases is contributing to some degree to better global health. But Giacomo Chiesi, head of Chiesi Global Rare Diseases, thinks of his 6,000-person company as a family business.

article thumbnail

Inflation threatens supply of life-saving generics to Europe

Pharmaceutical Technology

In a letter to energy ministers, they stated that raw material prices have risen by as much as 50–160% and transportation costs by up to 500%. It also stresses that some pharma manufacturers are at risk of having gas rationed or being unable to continue manufacturing due to high prices.